Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CRYPTOTANSHINONE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN ANTI-MYOCARDIAL FIBROSIS
Document Type and Number:
WIPO Patent Application WO/2022/257994
Kind Code:
A1
Abstract:
Disclosed are a cryptotanshinone derivative, a preparation method therefor and an application thereof in anti-myocardial fibrosis. The new cryptotanshinone derivative has a structural formula of (I). Preliminary experimental results show that the cryptotanshinone derivative has good anti-myocardial fibrosis activity and is expected to be developed as a novel anti-myocardial fibrosis drug.

Inventors:
LIU PEIQING (CN)
YIN SHENG (CN)
PAN WENJIE (CN)
LUO SIYUAN (CN)
Application Number:
PCT/CN2022/097738
Publication Date:
December 15, 2022
Filing Date:
June 08, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GUANGZHOU SYSU NANSHA SCIENCE & TECH INNOVATION PARK LTD CO (CN)
UNIV SUN YAT SEN (CN)
International Classes:
C07C50/24; A61P9/00; A61P9/10; C07C46/00; C07C46/10
Foreign References:
CN113307731A2021-08-27
CN113402372A2021-09-17
CN1196039A1998-10-14
CN106798737A2017-06-06
CN102603861A2012-07-25
Other References:
PING, XIAOFAN ET AL.: "Theoretical Study on the Structure Transformations of Cryptotanshinone and Tanshinone I with Hydrion or Hydroxide Ion", JOURNAL OF THEORETICAL AND COMPUTATIONAL CHEMISTRY: JTCC, WORLD SCIENTIFIC PUBL., US, vol. 8, no. 2, 31 December 2009 (2009-12-31), US , XP009541822, ISSN: 0219-6336, DOI: 10.1142/S0219633609004757
LO S H; HSU C T; NIU H S; NIU C S; CHENG J T; CHEN Z C: "Cryptotanshinone Inhibits STAT3 Signaling to Alleviate Cardiac Fibrosis in Type 1-like Diabetic Rats", PHYSIOTHERAPY RESEARCH, JOHN WILEY & SONS LTD. CHICHESTER., GB, 1 April 2017 (2017-04-01), GB , pages 638 - 646, XP018529908, ISSN: 0951-418X
Attorney, Agent or Firm:
GUANGZHOU NUOFENG INTELLECTUAL PROPERTY AGENT (CN)
Download PDF: